Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pablo Stutzbach is active.

Publication


Featured researches published by Pablo Stutzbach.


Revista Espanola De Cardiologia | 2003

Predictores de mortalidad hospitalaria en 186 episodios de endocarditis infecciosa activa en un centro de tercer nivel (1992-2001)

J. Horacio Casabé; Héctor Deschle; Claudia Cortés; Pablo Stutzbach; Alejandro Hershson; Claudia Nagel; Eduardo Guevara; Augusto Torino; Héctor Raffaelli; Roberto Favaloro; Luis D. Suárez

Introduction and objectives. The aim of this study was to describe the predictors of hospital mortality found in patients admitted for infective endocarditis (IE) to a cardiovascular surgery ward. Patients and method. Prospective study of 186 patients with IE treated in our hospital between 1992 and 2001. Results. One hundred fourteen patients (61.3%) had native valve endocarditis and 72 (38.7%) had prosthetic valve endocarditis (early in 28 patients [up to 12 months after surgery] and late in 44 [later than 12 months]). Blood cultures were positive in 82%. The predominant organism was Streptococcus viridans (36%) in native valve endocarditis and Staphylococcus aureus (33%) in prosthetic valve endocarditis. The hospital mortality was 22.6%. Severe sepsis (4.8%) produced a high mortality rate (88%) and was caused by Staphylococcus aureus in 60%. One hundred nineteen patients (64%) required surgery, 79 (66.4%) of them urgently. Negative blood cultures predicted need for surgery in native valve endocarditis (p < 0.05). The surgical mortality was 21.8% and was related to NYHA III-IV class (p = 0.014) and emergency surgery (p = 0.009) in patients with native valve endocarditis. This last factor also predicted higher surgical mortality in patients with early prosthetic valve endocarditis (p < 0.001). Conclusions. The hospital mortality of this group of patients with infective endocarditis treated in a tertiary medical center was high. The presence of severe sepsis, although infrequent, had a somber prognosis. Severe heart failure in native valve endocarditis and urgent surgery in native and prosthetic valve endocarditis increased surgical mortality.


The Annals of Thoracic Surgery | 1998

Valve operations through a minimally invasive approach

Ernesto Weinschelbaum; Pablo Stutzbach; Alejandro Machain; Roberto Favaloro; Victor Caramutti; Alejandro Bertolotti; Hugo Fraguas

BACKGROUND We analyzed in-hospital results of 87 patients undergoing minimally invasive valvular operations (right parasternal incision through third and fourth cartilages). METHODS Age was 21 to 84 years (mean, 56.2 +/- 16); 45 patients (51.7%) were female. Five (5.7%) had a previous valvular operation and 8 (9.2%) had severe left ventricular dysfunction. Valve diseases were as follows: aortic in 35 patients (40.2%), mitral in 44 (50.5%), double in 5 (5.7%), tricuspid regurgitation in 2 (2.2%), and mitral periprosthetic leak in 1 (1.1%). RESULTS Nineteen mitral repairs (21.9%), 22 replacements (25.3%), 1 leak closure (1.1%), 1 tricuspid repair (1.1%), and 1 replacement (1.1%) were performed. Thirty-one patients (35.7%) underwent aortic replacement, 2 (2.3%) aortic decalcification, 1 (1.1%) subaortic membrane resection, 4 (4.6%) a double-valve procedure, and 5 (5.7%) a single-valve operation combined with myocardial revascularization. In-hospital mortality was 5.7% (5 patients). Univariate analysis was significant for previous operation, New York Heart Association class IV and severe ventricular dysfunction. Multivariate analysis was significant for previous operation and severe ventricular dysfunction. Atrial fibrillation (12.6%) was the most frequent complication. Postoperative stay was 6.5 +/- 6 days. CONCLUSIONS The minimally invasive approach is a useful technique in valvular surgery. Patients with a previous valvular operation, severe ventricular dysfunction, and New York Heart Association class IV dyspnea have higher in-hospital mortality.


The Journal of Thoracic and Cardiovascular Surgery | 1999

Manual debridement of the aortic valve in elderly patients with degenerative aortic stenosis

Ernesto Weinschelbaum; Pablo Stutzbach; Martín Oliva; Javier Zaidman; Augusto Torino; Eduardo Gabe

OBJECTIVE We prospectively analyzed the short- and long-term results of manual debridement of the aortic valve in elderly patients with severe degenerative aortic stenosis. METHODS Between September 1988 and January 1997, 103 patients aged 73.7 +/- 6 years with degenerative aortic stenosis underwent the manual debridement technique. All had symptoms (angina or dyspnea, or both). Peak systolic gradient was 89 +/- 28 mm Hg. Forty-one patients (39.8%) had associated coronary artery disease necessitating revascularization. RESULTS Follow-up time was 42 +/- 21 months (range 3-98 months). The Kaplan-Meier estimated survival at 98 months was 50% (95% CI: 30%-70%). In-hospital mortality was 5.8% (6 patients), and late mortality was 21% (21 patients). No predictors of in-hospital mortality or of late mortality were detected. Nonfatal postoperative complications appeared in 25 patients (24%). At 8 years, freedom from endocarditis was 98% (95% CI: 95%-100%) and freedom from thromboembolic events was 99% (95% CI: 96%-100%). No patient required long-term anticoagulation as a result of the procedure. Fourteen patients (14%) required reoperation for aortic insufficiency (n = 5), restenosis (n = 8), and mitral regurgitation (n = 1). The probability of reoperation at 98 months was 23% (95% CI: 12%-35%). CONCLUSION Manual aortic valve debridement has low rates of in-hospital mortality, perioperative complications, and thromboembolic and infectious events and it offers freedom from anticoagulation. However, the incidence of restenosis and reoperation is high in the long term. It may therefore be regarded as an alternative in aged patients with favorable valve anatomy (no distortion and calcium deposits only on the aortic surface of the cusps), especially in those with a small aortic anulus, associated coronary artery disease, and/or contraindication for anticoagulation.


Journal of The American Society of Echocardiography | 2002

Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension

Miguel H. Bustamante‐Labarta; Sergio Perrone; Ricardo Leon de la Fuente; Pablo Stutzbach; Ricardo Pérez de la Hoz; Augusto Torino; Roberto Favaloro


Journal of the American College of Cardiology | 2006

Development of Mild Aortic Valve Stenosis in a Rabbit Model of Hypertension

Luis Cuniberti; Pablo Stutzbach; Eduardo Guevara; Gustavo G. Yannarelli; Rubén Laguens; Roberto Favaloro


Rev. argent. cardiol | 1999

Diagnóstico etiológico de la hipertensión pulmonar mediante eco transesofágico en candidatos a trasplante cardiopulmonar

Miguel Bustamante Labarta; Pablo Stutzbach; Eduardo Guevara; Ricardo Pérez de la Hoz; Mario O Fernández; Sergio Perrone; Augusto Torino; Luis D Suárez


Rev. argent. cardiol | 1999

Enfermedad de la válvula áortica: resultados a 3 años de la cirugía de Ross

Roberto Favaloro; Pablo Stutzbach; Victor Caramutti; Alejandro Machain; Carmen Gómez; J. Horacio Casabé; Martín Oliva; Mónica Alvarez


Rev. argent. cardiol | 1998

Descalcificación manual de válvula aórtica en pacientes con estenosis aórtica degenerativa senil

Ernesto Weinschelbaum; Pablo Stutzbach; Martín Oliva; Javier Zaidman; Augusto Torino; Eduardo Guevara; Eduardo Gabe


Prensa méd. argent | 2006

Patrones de adaptación anatómica del ventrículo izquierdo en la hipertensión sostenida de origen renovascular. Un estudio experimental

Luis Cuniberti; Eduardo Guevara; Gustavo Yannarelli; Pablo Stutzbach; Roberto Favaloro


Prensa méd. argent | 2005

Nuevo modelo experimental de Estenosis Valvular Aórtica

Luis Cunibeti; Pablo Stutzbach; Eduardo Guevara; Gustavo G. Yannarelli; Fernando Brites; Roberto Favaloro

Collaboration


Dive into the Pablo Stutzbach's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge